OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Current Status of Oligonucleotide-Based Protein Degraders
Po‐Chang Shih, Miyako Naganuma, Yosuke Demizu, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 765-765
Open Access | Times Cited: 6
Po‐Chang Shih, Miyako Naganuma, Yosuke Demizu, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 765-765
Open Access | Times Cited: 6
Showing 6 citing articles:
Expanding the horizons of targeted protein degradation: A non-small molecule perspective
Xiaowei Huang, Fengbo Wu, Jing Ye, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 6, pp. 2402-2427
Open Access | Times Cited: 14
Xiaowei Huang, Fengbo Wu, Jing Ye, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 6, pp. 2402-2427
Open Access | Times Cited: 14
Degraders upgraded: the rise of PROTACs in hematological malignancies
Joshua Casan, John F. Seymour
Blood (2024) Vol. 143, Iss. 13, pp. 1218-1230
Closed Access | Times Cited: 13
Joshua Casan, John F. Seymour
Blood (2024) Vol. 143, Iss. 13, pp. 1218-1230
Closed Access | Times Cited: 13
PROTAC technology: From drug development to probe technology for target deconvolution
Si Yan, Guangshuai Zhang, Wei Luo, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116725-116725
Closed Access | Times Cited: 10
Si Yan, Guangshuai Zhang, Wei Luo, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116725-116725
Closed Access | Times Cited: 10
Development of miRNA-based PROTACs targeting Lin28 for breast cancer therapy
Jianfei Xu, Xiaoran Zhao, Xingxing Liang, et al.
Science Advances (2024) Vol. 10, Iss. 38
Open Access | Times Cited: 2
Jianfei Xu, Xiaoran Zhao, Xingxing Liang, et al.
Science Advances (2024) Vol. 10, Iss. 38
Open Access | Times Cited: 2
Development of decoy oligonucleotide-warheaded chimeric molecules targeting STAT3
Po‐Chang Shih, Miyako Naganuma, Genichiro Tsuji, et al.
Bioorganic & Medicinal Chemistry (2023) Vol. 95, pp. 117507-117507
Closed Access | Times Cited: 6
Po‐Chang Shih, Miyako Naganuma, Genichiro Tsuji, et al.
Bioorganic & Medicinal Chemistry (2023) Vol. 95, pp. 117507-117507
Closed Access | Times Cited: 6
Ion Doped Hollow Silica Nanoparticles as Promising Oligonucleotide Delivery Systems to Mesenchymal Stem Cells
Chloe Trayford, Dina M. Ibrahim, Sabine van Rijt
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 9741-9755
Open Access
Chloe Trayford, Dina M. Ibrahim, Sabine van Rijt
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 9741-9755
Open Access
